High Burden of Multidrug-Resistant Candidozyma (formerly Candida) auris in a Tertiary Care Haematology Unit: Diagnostic Pitfalls and Identification of High-Risk Clinical Areas
Clicks: 3
ID: 315641
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #157 of 159 articles by views in medical mycology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 159 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Candidozyma (formerly Candida) auris is a multidrug-resistant critical priority pathogen, posing significant challenges in high-risk settings. This study was aimed to determine the proportion of C. auris among candidemia, evaluate automated antifungal susceptibility testing (AFST) against Broth Microdilution (BMD), and identify high risk areas in a haematology unit. A prospective cross-sectional study (September 2024-September 2025) screened 3 894 blood cultures in a Kolkata hospital. Isolates were identified via Vitek-2 and MALDI-TOF MS. Vitek 2 AFST results were compared with the gold-standard BMD. Spatial mapping was utilized to identify ward clustering. Excluding paediatric and non-haematology cases, the adult C. auris cohort (n = 38) was analyzed (mean age 25.8 ± 11.2 years). All had haematological malignancy and neutropenia, with central venous catheters in 81.6% (n = 31). The 30-day crude mortality was 15.8% (n = 6). Diagnostically Vitek 2 demonstrated a critical 47.4% Major Error rate for Amphotericin B compared to BMD (P < 0.001). significantly overestimating resistance. Spatial mapping identified persistent environmental reservoirs around specific high-traffic beds. Vitek 2 significantly overestimates Amphotericin B resistance, necessitating BMD verification to prevent inappropriate exclusion of polyene therapy. The infection burden in young, neutropenic adult highlights a vulnerable demographic. Persistence case clustering suggests environmental fomite colonization, requiring enhanced diagnostic stewardship and targeted sporicidal decontamination in haematology units.
| Reference Key |
openalex_W7163358118
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Suman Kundu, Chandana Banerjee, Swagata Ganguly Bhattacharjee |
| Journal | medical mycology |
| Year | 2026 |
| DOI |
10.1093/mmy/myag055
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.